NASDAQ
No price data available for this timeframe.
Lineage Cell Therapeutics, Inc. (LCTX) has a fcf yield of -5.06% as of Friday, May 29, 2026. This represents a 54.69% increase compared to its 12-month average of -11.17%. Free cash flow yield measures free cash flow per share as a percentage of the stock price, indicating cash return potential.